Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mono PharmacareNSE:MONOPHARMA -3.64%22 OCF Yield % is 3.49 as of Jul. 14, 2026. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 22/100. The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Mono Pharmacare ranks worse than 58.57% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Mono Pharmacare's OCF Yield % or its related term are showing as below:
NSE:MONOPHARMA'
s OCF Yield % Range Over the Past 10 Years
Min: -50.18 Med: -16.49 Max: 3.49
Current: 3.49
During the past 5 years, the highest OCF Yield % of Mono Pharmacare was 3.49%. The lowest was -50.18%. And the median was -16.49%.
NSE:MONOPHARMA's OCF Yield % is ranked worse than 58.57% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.47
vs NSE:MONOPHARMA: 3.49
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Mono Pharmacare OCF Yield % Related Terms
Mono Pharmacare OCF Yield % Historical Data
* Premium members only.
The historical data trend for Mono Pharmacare's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Mono Pharmacare's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mono Pharmacare OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Mono Pharmacare's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mono Pharmacare (NSE:MONOPHARMA) has a OCF Yield % of 3.49 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mono Pharmacare and its competitors. According to the industry distribution chart, Mono Pharmacare ranks #400 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 58.6%.
Is Mono Pharmacare's OCF Yield % too high?
Mono Pharmacare's current OCF Yield % is 3.49. The Healthcare Providers & Services industry median OCF Yield % is 5.47. Mono Pharmacare's value of 3.49 is 36.2% below this industry median. Based on the distribution chart, Mono Pharmacare ranks #400 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mono Pharmacare has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's OCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Mono Pharmacare ranks #400 out of 683 companies for OCF Yield %. This places Mono Pharmacare in the lower half of its industry. The industry median OCF Yield % is 5.47. Mono Pharmacare's value of 3.49 is 36.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mono Pharmacare's current OCF Yield % of 3.49 is 36.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mono Pharmacare and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mono Pharmacare's current OCF Yield % is 3.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current OCF Yield % of 3.49. The current OCF Yield % is 3.49 and 36.2% below the Healthcare Providers & Services industry median of 5.47. Mono Pharmacare's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current OCF Yield % is 3.49 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
22GF Score
Get the complete analysis for NSE:MONOPHARMA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MONOPHARMA has been successfully added to your 
